Idiopathic Pulmonary fibrosis (IPF) is a subset of interstitial ... Its availability, cost of scan and radiation risk are a few common hurdles why they may not be prescribed to patients.

The Pulmonary, Lung and Respiratory Imaging Sheffield ... for example in children with Cystic Fibrosis and adults with severe asthma, without using radiation. The methods are very sensitive to picking ...

Researchers have been trying for decades to stop the cells that damage the lung in people with pulmonary fibrosis. Now a team ...

Pulmonary fibrosis is a rare, chronic disease that causes scarring in the lungs, making breathing difficult for people who suffer with it.

Receiving a diagnosis for any disease/condition is not an easy experience. One organization hopes to make patients newly ...

Pulmonary fibrosis in patients with COVID-19 tends to resolve, while idiopathic pulmonary fibrosis always progresses.

Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers from the Technical University of Munich (TUM) have discovered that the ...

Eli Lilly is making a play for the idiopathic pulmonary fibrosis (IPF) market, offering Mediar Therapeutics $99 million in upfront and near-term payments for global rights to an asset that is ...

These results are important “for shared decision-making conversations between patients and clinicians, as many patients eligible for post mastectomy ... chest wall pain, fibrosis, heart damage ...